There are a lot of ASX shares out there for investors to choose from. So many, it can be hard to decide which ones to buy above others.
To narrow things down, let's take a look at two that the team at Bell Potter has named in its Core Portfolio.
These are essentially its best ideas and the ones it thinks would be top picks in the current environment. Here's what the broker is recommending to clients this month:
Amcor (ASX: AMC)
The first ASX share that could be a buy according to Bell Potter is Amcor.
The broker believes the Berry Global merger will be a game-changer and drive strong earnings growth in the coming years. It also expects to make Amcor to be less cyclical in the future. Bell Potter explains:
The investment thesis for Amcor is based on its transformative merger with Berry Global, which positions the company for a period of significant growth and quality improvement. The merger is expected to drive two years of double-digit EPS growth, fuelled by an estimated $590 million in synergies, with 80% anticipated to be realised within the first 24 months.
Beyond the near-term earnings growth, the merger also creates a more resilient and less cyclical business by increasing its exposure to the defensive home & personal care and pharmaceutical sectors.
WiseTech Global Ltd (ASX: WTC)
Bell Potter remains very bullish on this logistics solutions software company and has named it on its best ideas list this year.
The broker believes it would be a top option due to its strong growth outlook, which is being underpinned by its low churn levels, recurring revenue, and the recent acquisition of E2open. It said:
WiseTech is a leading global provider of software solutions to the logistics industry, with its market-leading CargoWise One platform used by many of the world's largest logistics providers. The company's quality is underpinned by a highly predictable business model, with around 95% of its revenue being recurring and a customer churn rate of less than 1%.
This provides clear and consistent cash flow, enabling a distinct path to deleverage, with management confident in reducing ND/EBITDA from ~3x in FY26 to 1.7x in FY27. Growth is set to scale both organically, through a new commercial model, and inorganically, with the recent E2open acquisition representing a significant opportunity to accelerate penetration into adjacent markets like trade.
